Overview
- CDC researchers, in a report published last week, detailed the BA.3.2 lineage spreading to 23 countries and appearing in U.S. wastewater and a small number of clinical samples.
- In the United States, the variant was first picked up through traveler screening at San Francisco International Airport in June 2025, with mid‑February data showing five patient samples across four states and 132 wastewater detections in about 25 states.
- BA.3.2 carries roughly 70–75 spike‑protein changes and showed the lowest antibody neutralization of seven tested variants against the 2025–26 vaccine in lab studies, although neutralization results do not equal real‑world protection.
- Surveillance from several European countries shows BA.3.2 co‑circulating at about 10%–40% rather than taking over, and U.S. case descriptions report no clear increase in severity, with all identified patients surviving.
- Health agencies are watching for signals that could guide a vaccine update and are leaning on wastewater and traveler‑based testing, which often reveal spread weeks before standard clinical sequencing.